Evidence map›Paper›PMID 34489944›Full record

ArticleFrontiers in immunology2021

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia.

Pavel V Shelyakin, Ksenia R Lupyr, Evgeny S Egorov, Ilya A Kofiadi, Dmitriy B Staroverov, Sofya A Kasatskaya, Valeriia V Kriukova, Irina A Shagina, Ekaterina M Merzlyak, Tatiana O Nakonechnaya and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. T Cell Thoughts.Immunological reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review.Clinical reviews in allergy & immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Pavel V ShelyakinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Ksenia R LupyrShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Evgeny S EgorovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Ilya A KofiadiFSBI "NRC Institute of Immunology" FMBA of Russia, Moscow, Russia.
Dmitriy B StaroverovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Sofya A KasatskayaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Valeriia V KriukovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Irina A ShaginaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Ekaterina M MerzlyakShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Tatiana O NakonechnayaInstitute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Elena A LatyshevaFSBI "NRC Institute of Immunology" FMBA of Russia, Moscow, Russia.
Irina A MantoFSBI "NRC Institute of Immunology" FMBA of Russia, Moscow, Russia.
Musa R KhaitovFSBI "NRC Institute of Immunology" FMBA of Russia, Moscow, Russia.
Sergey A LukyanovInstitute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Dmitriy M ChudakovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Olga V BritanovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Institute of Bioorganic Chemistry · RUPirogov Russian National Research Medical University · RUInstitute of Immunology and Physiology · RUSkolkovo Institute of Science and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between T- and B-cell compartments during naïve, effector and memory T cell maturation is critical for a balanced immune response. Primary B-cell immunodeficiency arising from X-linked agammaglobulinemia (XLA) offers a model to explore B cell impact on T cell subsets, starting from the thymic selection. Here we investigated characteristics of naïve and effector T cell subsets in XLA patients, revealing prominent alterations in the corresponding T-cell receptor (TCR) repertoires. We observed immunosenescence in terms of decreased diversity of naïve CD4

Indexed as

AdolescentAdultAgammaglobulinemiaAgedAged, 80 and overB-LymphocytesCase-Control StudiesComplementarity Determining RegionsGenes, T-Cell Receptor betaGenetic Diseases, X-LinkedHumansImmunosenescenceMaleMemory T CellsMiddle AgedModels, ImmunologicalComplementarity Determining RegionsCDR3β featuresnaïve regulatory T cellsT cell gene expressionTCR repertoireX-linked agammaglobulinemia (XLA)

Identifiers

PMID34489944
PMCPMC8417104
OpenAlexW3196208401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.